EyePoint (EYPT) Cash & Current Investments (2010 - 2026)

EyePoint (EYPT) reported Cash & Current Investments of $222.5 million for Q1 2026, down 30.06% on a YoY basis from $318.2 million in Q1 2025, and down 27.29% sequentially from $306.1 million in Q4 2025.

EyePoint (EYPT) Cash & Current Investments (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of Cash & Current Investments data on file, last reported at $222.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 30.06% year-over-year to $222.5 million; the trailing twelve-month figure through Mar 2026 stood at $222.5 million (down 30.06% YoY), and the FY2025 full-year result was $306.1 million, down 17.48% from the prior year.
  • Cash & Current Investments declined to $222.5 million in Q1 2026, from $306.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $370.9 million in Q4 2024 to a low of $122.5 million in Q1 2023.
  • A 5-year average of $229.8 million and a median of $222.5 million in 2026 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments sank 35.81% in 2023 and surged 144.44% in 2024, its largest moves.
  • Tracing EYPT's Cash & Current Investments over 5 years: stood at $144.6 million in 2022, then surged by 129.0% to $331.0 million in 2023, then increased by 12.04% to $370.9 million in 2024, then slipped by 17.48% to $306.1 million in 2025, then fell by 27.29% to $222.5 million in 2026.
  • Business Quant data shows EYPT's Cash & Current Investments at $222.5 million in Q1 2026, $306.1 million in Q4 2025, and $204.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 EyePoint 1.07 Mn -221.48 Mn 168,000.00 222.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 222.55 Mn
Dec 31, 2025 306.09 Mn
Sep 30, 2025 204.02 Mn
Jun 30, 2025 255.73 Mn
Mar 31, 2025 318.19 Mn
Dec 31, 2024 370.91 Mn
Sep 30, 2024 253.79 Mn
Jun 30, 2024 280.25 Mn
Mar 31, 2024 299.35 Mn
Dec 31, 2023 331.05 Mn
Sep 30, 2023 136.01 Mn
Jun 30, 2023 142.50 Mn
Mar 31, 2023 122.47 Mn
Dec 31, 2022 144.56 Mn
Sep 30, 2022 157.26 Mn
Jun 30, 2022 171.17 Mn
Mar 31, 2022 190.78 Mn
Dec 31, 2021 211.56 Mn
Sep 30, 2021 119.71 Mn
Jun 30, 2021 127.60 Mn